The first stop for professional medicines advice

Guidance

625 results

Applied filters

Ziconotide: informing intrathecal risk assessment

16 May 2025Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Clonidine: informing intrathecal risk assessment

16 May 2025Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Unlicensed medicines podcast series

13 May 2025A series of podcasts about unlicensed medicines

What’s new in medicines mechanisms and governance PGDs

13 May 2025An update for those involved in medicines governance including managing PGDs and other medicine mechanisms in practice. 13 May 2025.

Investigating deviations and establishing root causes in aseptic services

8 May 2025An SPS Quality Assurance (QA) bite size learning event on deviation investigation and establishing root causes in pharmacy aseptic services. 27 June 2025.

Baclofen: informing intrathecal risk assessment

7 May 2025Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Patient Group Directions and legal mechanisms

All our resources on Patient Group Directions (PGDs) and other legal mechanisms for the supply or administration of medicines.

Developing insulin safety across a system

1 May 2025Strategies, signposting and initiatives to support safer use of insulin.

Managing PGDs following organisational change

30 April 2025Advice on the management of PGDs when organisations merge, cease to exist or services are transferred to a new provider to ensure safe care and good governance

Retaining legal mechanism documentation

30 April 2025Advice on the retention of all records relating to legal mechanisms, such as PSDs, PGDs, Written Instructions and National Protocols